To determine whether conduit artery size affects functional responses, we compared the magnitude, time course, and eliciting shear rate stimulus for flow-mediated dilation (FMD) in healthy men (n ϭ 20; 31 Ϯ 7 yr). Upper limb (brachial and radial) and lower limb (common and superficial femoral) FMD responses were simultaneously assessed, whereas popliteal responses were measured in the same subjects during a separate visit. Glyceryl trinitrate (GTN)-mediated responses were similarly examined. Edge detection and wall tracking of highresolution B-mode arterial ultrasound images, combined with synchronized Doppler waveform envelope analysis, were used to calculate conduit artery diameter, blood flow, and shear rate continuously across the cardiac cycle. Baseline artery size correlated inversely with the FMD response (r ϭ Ϫ0.57, P Ͻ 0.001). Within-artery comparisons revealed a significant inverse correlation between artery size and FMD% for the radial (r ϭ Ϫ0.66, P ϭ 0.001), brachial (r ϭ Ϫ0.55, P ϭ 0.01), and popliteal artery (r ϭ Ϫ0.48, P ϭ 0.03), but not for the superficial and common femoral artery. Normalization of FMD responses for differences in eliciting shear rate did not abolish the between-artery relationship for artery function and size (r ϭ Ϫ0.48, P Ͻ 0.001), suggesting that differences between artery function responses were not entirely due to size-related differences in shear rate. This was reinforced by a significant between-artery correlation for GTN responses and baseline artery size (r ϭ Ϫ0.74, P Ͻ 0.001). In summary, systematic differences exist in vascular function responses of conduit arteries that differ in size. This raises the possibility that differences in artery size within or between individuals may influence functional responses. flow-mediated dilation; nitroglycerine; arterial diameter; high-resolution ultrasound; Doppler MEASURES OF ARTERIAL FUNCTION have increasingly been adopted as surrogate markers of cardiovascular risk (31). For example, conduit artery vasodilation to a 5-min ischemic period, commonly referred to as flow-mediated dilation (FMD), reflects bioactivity of endothelium-derived nitric oxide (NO) (14, 17), which possesses myriad antiatherogenic effects (31). Endothelial dysfunction can be considered an early and integral manifestation of vascular disease that predicts cardiovascular events (8,15,16,18,21), whereas improvement in endothelial function impacts significantly on cardiovascular risk (10,11,16).For many years, it has been recognized that baseline artery diameter correlates strongly with the magnitude of the FMD response. It was recently proposed that this relationship might be explained as a consequence of smaller arteries being exposed, by virtue of their size, to a greater shear stress stimulus during reactive hyperemia. In relative terms, this results in enhanced dilator responses compared with arteries of larger dimension (25,27,28). Correcting the FMD response to the magnitude of the shear stress stimulus may eliminate the between-subject variability (23)....